Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease

Marcello Tonelli1, S Ananth Karumanchi2, Ravi Thadhani2

  • 1From Department of Medicine, University of Calgary, AB, Canada (M.T.); Department of Medicine and Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and Howard Hughes Medical Institute, Chevy Chase, MD (S.A.K..); and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston (R.T.). tonelli.admin@ucalgary.ca.

Circulation
|February 3, 2016
PubMed

Insights

Patients with chronic kidney disease (CKD) face a significantly higher risk of cardiovascular disease (CVD). Uremia-specific factors, beyond traditional risks, drive CVD in CKD patients, necessitating targeted research and improved management strategies.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) exhibit a 5- to 10-fold increased risk of cardiovascular disease (CVD) compared to age-matched individuals.
  • CVD in this population presents as coronary artery disease, arrhythmias, stroke, and congestive heart failure.
  • Traditional risk factors like diabetes and hypertension are compounded by uremia-specific factors from toxin accumulation in the pathogenesis of CVD.

Purpose of the Study:

  • To review the epidemiology of traditional and uremia-related CVD in CKD patients.
  • To explore the postulated mechanisms of uremia-specific CVD pathogenesis.
  • To identify gaps in current CVD diagnostics and therapies for CKD patients and suggest future research directions.

Main Methods:

  • Literature review of epidemiological studies on CVD in CKD.
  • Analysis of postulated mechanisms linking uremia to CVD.
  • Evaluation of current and emerging CVD diagnostics and therapies in the context of CKD management.

Main Results:

  • CKD and ESRD significantly elevate CVD risk.
  • Uremia-specific factors play a crucial role in CVD development in these patients.
  • Significant gaps exist in the medical management of CVD in the growing CKD population.

Conclusions:

  • Targeted epidemiological and translational research is essential to address the gaps in managing CVD in CKD patients.
  • Global challenges in recognizing and managing uremia-related CVD require attention in both developed and developing nations.
  • A comprehensive approach integrating understanding of traditional and uremia-specific factors is needed for effective CVD management in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
586
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.8K